2024 Q3 Form 10-Q Financial Statement

#000147793224005700 Filed on September 13, 2024

View on sec.gov

Income Statement

Concept 2024 Q3
Revenue $0.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin
YoY Change
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses $2.675K
YoY Change -39.31%
Operating Profit -$2.675K
YoY Change -39.31%
Interest Expense
YoY Change
% of Operating Profit
Other Income/Expense, Net
YoY Change
Pretax Income
YoY Change
Income Tax
% Of Pretax Income
Net Earnings -$2.675K
YoY Change -39.31%
Net Earnings / Revenue
Basic Earnings Per Share
Diluted Earnings Per Share
COMMON SHARES
Basic Shares Outstanding 120.0M shares
Diluted Shares Outstanding

Balance Sheet

Concept 2024 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $0.00
YoY Change
Cash & Equivalents $0.00
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets $0.00
YoY Change
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $0.00
YoY Change
TOTAL ASSETS
Total Short-Term Assets $0.00
Total Long-Term Assets $0.00
Total Assets $0.00
YoY Change
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $8.825K
YoY Change -7.16%
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt $143.9K
YoY Change 19.06%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $152.7K
YoY Change 17.15%
LONG-TERM LIABILITIES
Long-Term Debt $0.00
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $152.7K
Total Long-Term Liabilities $0.00
Total Liabilities $152.7K
YoY Change 17.15%
SHAREHOLDERS EQUITY
Retained Earnings -$212.7K
YoY Change 11.74%
Common Stock $120.0K
YoY Change 0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$152.7K
YoY Change
Total Liabilities & Shareholders Equity $0.00
YoY Change

Cashflow Statement

Concept 2024 Q3
OPERATING ACTIVITIES
Net Income -$2.675K
YoY Change -39.31%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities -$2.750K
YoY Change -22.97%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 2.750K
YoY Change -22.97%
NET CHANGE
Cash From Operating Activities -2.750K
Cash From Investing Activities
Cash From Financing Activities 2.750K
Net Change In Cash 0.000
YoY Change
FREE CASH FLOW
Cash From Operating Activities -$2.750K
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
us-gaap Operating Income Loss
OperatingIncomeLoss
-18667 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-13979 usd
CY2024Q3 us-gaap Net Income Loss
NetIncomeLoss
-2675 usd
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
-4408 usd
CY2024Q3 us-gaap Net Income Loss
NetIncomeLoss
-2675 usd
CY2024Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-212693 usd
CY2024Q3 us-gaap Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
0 usd
CY2023Q4 us-gaap Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
0 usd
dei Entity Central Index Key
EntityCentralIndexKey
0001544400
dei Amendment Flag
AmendmentFlag
false
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--10-31
dei Document Period End Date
DocumentPeriodEndDate
2024-07-31
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2024
dei Entity Ex Transition Period
EntityExTransitionPeriod
false
dei Document Transition Report
DocumentTransitionReport
false
CY2023Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2023Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
450000000 shares
CY2023Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
120000000 shares
CY2023Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
120000000 shares
CY2024Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
120000000 shares
CY2023Q4 nftn Due To Related Party Current
DueToRelatedPartyCurrent
6744 usd
CY2023Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2023Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
120000000 shares
CY2023Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
120000000 shares
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Entity File Number
EntityFileNumber
333-180164
dei Entity Registrant Name
EntityRegistrantName
NFiniTi inc.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
NV
dei Entity Address Address Line1
EntityAddressAddressLine1
Pampana 18
dei Entity Address Address Line2
EntityAddressAddressLine2
La Cruz, C.P.
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
63734
dei Entity Address Address Line3
EntityAddressAddressLine3
La Cruz de Huanacaxtle
dei Entity Address City Or Town
EntityAddressCityOrTown
Nayarit
dei Entity Address Country
EntityAddressCountry
MX
dei City Area Code
CityAreaCode
523
dei Local Phone Number
LocalPhoneNumber
221984348
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
true
dei Entity Shell Company
EntityShellCompany
true
CY2024Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
120000000 shares
CY2024Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
0 usd
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
0 usd
CY2024Q3 us-gaap Assets Current
AssetsCurrent
0 usd
CY2023Q4 us-gaap Assets Current
AssetsCurrent
0 usd
CY2024Q3 us-gaap Assets
Assets
0 usd
CY2023Q4 us-gaap Assets
Assets
0 usd
CY2024Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
8825 usd
CY2023Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
10357 usd
CY2024Q3 us-gaap Loans Payable Current
LoansPayableCurrent
137124 usd
CY2023Q4 us-gaap Loans Payable Current
LoansPayableCurrent
116925 usd
CY2024Q3 us-gaap Other Loans Payable Current
OtherLoansPayableCurrent
6744 usd
CY2023Q4 us-gaap Other Loans Payable Current
OtherLoansPayableCurrent
6744 usd
CY2024Q3 us-gaap Liabilities Current
LiabilitiesCurrent
152693 usd
CY2023Q4 us-gaap Liabilities Current
LiabilitiesCurrent
134026 usd
CY2024Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2024Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
450000000 shares
CY2024Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
120000000 shares
CY2024Q3 us-gaap Common Stock Value
CommonStockValue
120000 usd
CY2023Q4 us-gaap Common Stock Value
CommonStockValue
120000 usd
CY2024Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
-60000 usd
CY2023Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
-60000 usd
CY2024Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-212693 usd
CY2023Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-194026 usd
CY2024Q3 us-gaap Stockholders Equity
StockholdersEquity
-152693 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
-134026 usd
CY2024Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
0 usd
CY2023Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
0 usd
CY2024Q3 us-gaap Revenues
Revenues
0 usd
CY2023Q3 us-gaap Revenues
Revenues
0 usd
us-gaap Revenues
Revenues
0 usd
us-gaap Revenues
Revenues
0 usd
CY2024Q3 us-gaap Professional Fees
ProfessionalFees
2675 usd
CY2023Q3 us-gaap Professional Fees
ProfessionalFees
4408 usd
us-gaap Professional Fees
ProfessionalFees
18667 usd
us-gaap Professional Fees
ProfessionalFees
13979 usd
CY2024Q3 us-gaap Operating Expenses
OperatingExpenses
2675 usd
CY2023Q3 us-gaap Operating Expenses
OperatingExpenses
4408 usd
us-gaap Operating Expenses
OperatingExpenses
18667 usd
us-gaap Operating Expenses
OperatingExpenses
13979 usd
CY2024Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-2675 usd
CY2023Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-4408 usd
us-gaap Net Income Loss
NetIncomeLoss
-18667 usd
us-gaap Net Income Loss
NetIncomeLoss
-13979 usd
CY2024Q3 nftn Earnings Per Common Share Basic And Diluted
EarningsPerCommonShareBasicAndDiluted
-0.00
CY2023Q3 nftn Earnings Per Common Share Basic And Diluted
EarningsPerCommonShareBasicAndDiluted
-0.00
nftn Earnings Per Common Share Basic And Diluted
EarningsPerCommonShareBasicAndDiluted
-0.00
nftn Earnings Per Common Share Basic And Diluted
EarningsPerCommonShareBasicAndDiluted
-0.00
CY2024Q3 nftn Weighted Average Number Of Common Share Outstanding Basic And Diluted
WeightedAverageNumberOfCommonShareOutstandingBasicAndDiluted
120000000 shares
CY2023Q3 nftn Weighted Average Number Of Common Share Outstanding Basic And Diluted
WeightedAverageNumberOfCommonShareOutstandingBasicAndDiluted
120000000 shares
nftn Weighted Average Number Of Common Share Outstanding Basic And Diluted
WeightedAverageNumberOfCommonShareOutstandingBasicAndDiluted
120000000 shares
nftn Weighted Average Number Of Common Share Outstanding Basic And Diluted
WeightedAverageNumberOfCommonShareOutstandingBasicAndDiluted
120000000 shares
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
-134026 usd
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
-11567 usd
CY2024Q1 us-gaap Stockholders Equity
StockholdersEquity
-145593 usd
CY2024Q2 us-gaap Net Income Loss
NetIncomeLoss
-4425 usd
CY2024Q2 us-gaap Stockholders Equity
StockholdersEquity
-150018 usd
CY2024Q3 us-gaap Stockholders Equity
StockholdersEquity
-152693 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
-116363 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-6198 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
-122561 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-3373 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
-125934 usd
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
-4408 usd
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
-130342 usd
us-gaap Profit Loss
ProfitLoss
-18667 usd
us-gaap Profit Loss
ProfitLoss
-13979 usd
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-1532 usd
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-696 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-20199 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-14674 usd
nftn Proceeds From Loan Payable Shareholders
ProceedsFromLoanPayableShareholders
20199 usd
nftn Proceeds From Loan Payable Shareholders
ProceedsFromLoanPayableShareholders
14674 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
20199 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
14674 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
0 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
0 usd
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
0 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
0 usd
CY2024Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
0 usd
CY2023Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
0 usd
CY2024Q3 nftn Working Capital Deficits
WorkingCapitalDeficits
-152693 usd
CY2023Q4 nftn Working Capital Deficits
WorkingCapitalDeficits
-134026 usd
us-gaap Use Of Estimates
UseOfEstimates
<p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The preparation of financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates. </p>
us-gaap Revenue Recognition Deferred Revenue
RevenueRecognitionDeferredRevenue
<p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The Company records revenue on an accrual basis when all goods and services have been performed and delivered, the amounts are readily determinable, and collection is reasonably assured.  The Company has not generated any revenue since its inception.</p>
CY2024Q3 nftn Due To Related Party Current
DueToRelatedPartyCurrent
6744 usd
nftn Proceeds From Loan Payable Shareholders
ProceedsFromLoanPayableShareholders
20199 usd
CY2024Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2023Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
450000000 shares
CY2024Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
120000000 shares

Files In Submission

Name View Source Status
0001477932-24-005700-index-headers.html Edgar Link pending
0001477932-24-005700-index.html Edgar Link pending
0001477932-24-005700.txt Edgar Link pending
0001477932-24-005700-xbrl.zip Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
nftn-20240731.xsd Edgar Link pending
nftn_10q.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
nftn-20240731_cal.xml Edgar Link unprocessable
nftn-20240731_def.xml Edgar Link unprocessable
nftn-20240731_lab.xml Edgar Link unprocessable
nftn-20240731_pre.xml Edgar Link unprocessable
nftn_10q_htm.xml Edgar Link completed
nftn_ex31.htm Edgar Link pending
nftn_ex32.htm Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R2.htm Edgar Link pending
R3.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending